Clinical Trial Update: Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subconjunctival aflibercept for Irvine-Gass syndrome–related macular edema after cataract surgery; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irvine-gass Syndrome

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Tufts Medical Center | Conditions: Irvine-Gass Syndrome | Phase 1 | Status: TERMINATED